Q/C Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell QCLS and other ETFs, options, and stocks.About QCLS
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms.
CEOChristopher C. Chapman, Jr., MD
CEOChristopher C. Chapman, Jr., MD
Employees2
Employees2
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1989
Founded1989
Employees2
Employees2
QCLS Key Statistics
Market cap28.83M
Market cap28.83M
Price-Earnings ratio-0.05
Price-Earnings ratio-0.05
Dividend yield—
Dividend yield—
Average volume15.17M
Average volume15.17M
High today$8.27
High today$8.27
Low today$4.46
Low today$4.46
Open price$5.48
Open price$5.48
Volume96.02M
Volume96.02M
52 Week high$164.00
52 Week high$164.00
52 Week low$2.50
52 Week low$2.50
Stock Snapshot
With a market cap of 28.83M, Q/C Technologies(QCLS) trades at $8.00. The stock has a price-to-earnings ratio of -0.05.
During the trading session on 2025-12-05, Q/C Technologies(QCLS) shares reached a daily high of $8.27 and a low of $4.46. At a current price of $8.00, the stock is +79.5% higher than the low and still -3.3% under the high.
Trading activity shows a volume of 96.02M, compared to an average daily volume of 15.17M.
Over the past 52 weeks, Q/C Technologies(QCLS) stock has traded between a high of $164.00 and a low of $2.50.
Over the past 52 weeks, Q/C Technologies(QCLS) stock has traded between a high of $164.00 and a low of $2.50.
People also own
Based on the portfolios of people who own QCLS. This list is generated using Robinhood data, and it’s not a recommendation.